Intracellular redistribution of protein kinase D2 in response to G-protein-coupled receptor agonists

Biochemical and Biophysical Research Communications

Volumn 302, Issue 4, 2003, Pages 817-824

  Rey, Osvaldo ^a   Yuan, Jingzhen ^a   Rozengurt, Enrique ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G protein coupled receptors; Green fluorescent protein; Neurotensin; Panc 1 cells; Protein kinase C; Protein kinase D2

Indexed keywords

G PROTEIN COUPLED RECEPTOR; ISOENZYME; NEUROTENSIN; PROTEIN KINASE C; PROTEIN KINASE D2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEADY STATE;

EID: 0037459191     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00269-9     Document Type: Article

References (43)

1. Johannes F.J., Prestle J., Eis S., Oberhagemann P., Pfizenmaier K. PKCu is a novel, a typical member of the protein kinase C family. J. Biol. Chem. 269:1994;6140-6148.
2. Valverde A.M., Sinnett-Smith J., Van Lint J., Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. USA. 91:1994;8572-8576.
3. Sturany S., Van Lint J., Muller F., Wilda M., Hameister H., Hocker M., Brey A., Gern U., Vandenheede J., Gress T., Adler G., Seufferlein T. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J. Biol. Chem. 276:2001;3310-3318.
4. Hayashi A., Seki N., Hattori A., Kozuma S., Saito T. PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochim. Biophys. Acta. 1450:1999;99-106.
5. Waldron R.T., Iglesias T., Rozengurt E. The pleckstrin homology domain of protein kinase D interacts preferentially with the eta isoform of protein kinase C. J. Biol. Chem. 274:1999;9224-9230.
6. Iglesias T., Rozengurt E. Protein kinase D activation by mutations within its pleckstrin homology domain. J. Biol. Chem. 273:1998;410-416.
7. Rozengurt E., Sinnett-Smith J., Zugaza J.L. Protein kinase D: a novel target for diacylglycerol and phorbol esters. Biochem. Soc. Trans. 25:1997;565-571.
8. Iglesias T., Rozengurt E. Protein kinase D activation by deletion of its cysteine-rich motifs. FEBS Lett. 454:1999;53-56.
9. Iglesias T., Matthews S., Rozengurt E. Dissimilar phorbol ester binding properties of the individual cysteine-rich motifs of protein kinase D. FEBS Lett. 437:1998;19-23.
10. Storz P., Hausser A., Link G., Dedio J., Ghebrehiwet B., Pfizenmaier K., Johannes F.J. Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32. J. Biol. Chem. 275:2000;24601-24607.
11. Prestle J., Pfizenmaier K., Brenner J., Johannes F.J. Protein kinase C mu is located at the Golgi compartment. J. Cell Biol. 134:1996;1401-1410.
12. Matthews S.A., Iglesias T., Rozengurt E., Cantrell D. Spatial and temporal regulation of protein kinase D (PKD). EMBO J. 19:2000;2935-2945.
13. Matthews S., Iglesias T., Cantrell D., Rozengurt E. Dynamic re-distribution of protein kinase D (PKD) as revealed by a GFP-PKD fusion protein: dissociation from PKD activation. FEBS Lett. 457:1999;515-521.
14. Rey O., Rozengurt E. Protein kinase D interacts with golgi via its cysteine-rich domain. Biochem. Biophys. Res. Commun. 287:2001;21-26.
15. Rey O., Young S.H., Cantrell D., Rozengurt E. Rapid protein kinase D translocation in response to G protein-coupled receptor activation: dependence on protein kinase C. J. Biol. Chem. 276:2001;32616-32626.
16. Rey O., Sinnett-Smith J., Zhukova E., Rozengurt E. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J. Biol. Chem. 276:2001;49228-49235.
17. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Krawetz S., Misener S. Bioinformatics Methods and Protocols: Methods in Molecular Biology. 2000;365-386 Humana Press, Totowa, NJ.
18. Dekker L.V., McIntyre P., Parker P.J. Mutagenesis of the regulatory domain of rat protein kinase C-η. A molecular basis for restricted histone kinase activity. J. Biol. Chem. 268:1993;19498-19504.
19. Genot E.M., Parker P.J., Cantrell D.A. Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation. J. Biol. Chem. 270:1995;9833-9839.
20. Sturany S., Van Lint J., Gilchrist A., Vandenheede J.R., Adler G., Seufferlein T. Mechanism of activation of protein kinase D2(PKD2) by the CCK(B)/gastrin receptor. J. Biol. Chem. 277:2002;29431-29436.
21. Guha S., Rey O., Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res. 62:2002;1632-1640.
22. Ryder N.M., Guha S., Hines O.J., Reber H.A., Rozengurt E. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J. Cell. Physiol. 186:2001;53-64.
23. Kusama T., Mukai M., Iwasaki T., Tatsuta M., Matsumoto Y., Akedo H., Nakamura H. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res. 61:2001;4885-4891.
24. Kornmann M., Arber N., Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Invest. 101:1998;344-352.
25. Kornmann M., Danenberg K.D., Arber N., Beger H.G., Danenberg P.V., Korc M. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res. 59:1999;3505-3511.
26. Giehl K., Skripczynski B., Mansard A., Menke A., Gierschik P. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene. 19:2000;2930-2942.
27. Giehl K., Seidel B., Gierschik P., Adler G., Menke A. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene. 19:2000;4531-4541.
28. Ellenrieder V., Hendler S.F., Boeck W., Seufferlein T., Menke A., Ruhland C., Adler G., Gress T.M. Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 61:2001;4222-4228.
29. Waldron R., Rey O., Iglesis T., Tugal T., Cantrell D., Rozengurt E. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276:2001;32606-32615.
30. Waldron R.T., Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem. 278:2003;154-163.
31. Yuan J., Slice L.W., Gu J., Rozengurt E. Cooperation of Gq, Gi and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid. J. Biol. Chem. 10:2002;10.
32. Jamora C., Yamanouye N., Van Lint J., Laudenslager J., Vandenheede J.R., Faulkner D.J., Malhotra V. G. βγ -mediated regulation of Golgi organization is through the direct activation of protein kinase D Cell. 98:1999;59-68.
33. Wang L., Friess H., Zhu Z., Graber H., Zimmermann A., Korc M., Reubi J.C., Buchler M.W. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin. Cancer Res. 6:2000;566-571.
34. Elek J., Pinzon W., Park K.H., Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res. 20:2000;53-58.
35. Reubi J.C., Waser B., Friess H., Buchler M., Laissue J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut. 42:1998;546-550.
36. Ben-Levy R., Hooper S., Wilson R., Paterson H.F., Marshall C.J. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr. Biol. 8:1998;1049-1057.
37. Kaffman A., O'Shea E.K. Regulation of nuclear localization: a key to a door. Ann. Rev. Cell Develop. Biol. 15:1999;291-339.
38. Brownawell A.M., Kops G.J., Macara I.G., Burgering B.M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21:2001;3534-3546.
39. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
40. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 278:1997;141-144.
41. Ullman K.S., Powers M.A., Forbes D.J. Nuclear export receptors: from importin to exportin [comment]. Cell. 90:1997;967-970.
42. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4:1997;139-147.
43. Zugaza J.L., Sinnett-Smith J., Van Lint J., Rozengurt E. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 15:1996;6220-6230.